Tago Fiffu-Gen, Orosomucoid

FDA 510(k) K841734 · Tago, Inc.

Substantially Equivalent

510(k) numberK841734

Submission

Device name
Tago Fiffu-Gen, Orosomucoid
Applicant
Tago, Inc.
Mchenry, IL, US
Received
April 26, 1984
Decision date
June 1, 1984
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
LKL – Alpha-1-Acid-Glycoprotein, Antigen, Antiserum, Control
Device class
Class I (low risk)
Regulation
21 CFR 866.5420
Specialty
Immunology

Other 510(k)s with product code LKL

510(k)DeviceApplicantDecision
K993441K-Assay ALPHA-1 AGLKL · Traditional Kamiya Biomedical Co.11/24/1999SE
K964299N-Assay Tia Multi V-NlLKL · Traditional Crestat Diagnostics, Inc.07/14/1997SE
K964257Immage Immunochemistry System ALPHA-1-ACID Glycoprotein (Aag) ReagentLKL · Traditional Beckman Instruments, Inc.03/24/1997SE
K922417Al-Acid Glycoprotein Rid KitLKL · Traditional The Binding Site, Ltd.08/20/1992SE
K904175Raichem (TM) Spia (TM) - Acid Glycoprotein ReagentLKL · Traditional Reagents Applications, Inc.11/13/1990SE
K884217Technicon DPA-1 Analyte Alpha 1 Acid GlycoproteinLKL · Traditional Technicon Instruments Corp.11/04/1988SE
K873868ALPHA-1-ACID Glycoprotein (Orosomucoid)LKL · Traditional Unipath , Ltd.10/20/1987SE
K862087Santest 1APLKL · Traditional Scientific Sales Intl., Inc.12/03/1986SE
K861336Iap Plate TestLKL · Traditional Scientific Sales Intl., Inc.04/25/1986SE
K831960Test for Human Alpha One Acid Glyco-LKL · Traditional Kent Laboratories, Inc.07/19/1983SE

More from Kent Laboratories, Inc.

510(k)DeviceDecision
K841265Tago Diffu-Gen C-Reactive ProteinDCN · Traditional 05/22/1984SE
K834218Diffu-Gen Apolipoprotein A-I Radial -MSJ · Traditional 05/11/1984SE
K840404Diffu-Gen Haptoglobin Radial ImmunoDAD · Traditional 03/09/1984SE
K833129Tago Diffu-Gen-Apolipoprotein B-100MSJ · Traditional 11/21/1983SE
K830611Ra Screening TestDHR · Traditional 03/24/1983SE
K830531Mono Screening TestKTN · Traditional 03/17/1983SE
K830156HCG Screening TestJHJ · Traditional 02/09/1983SE

Questions and answers

When was Tago Fiffu-Gen, Orosomucoid cleared by the FDA?

Tago Fiffu-Gen, Orosomucoid (K841734) received a 510(k) decision of Substantially Equivalent on June 1, 1984, 36 days after the submission was received.

What is the product code of K841734?

The FDA product code is LKL – Alpha-1-Acid-Glycoprotein, Antigen, Antiserum, Control, a Class I (low risk) device regulated under 21 CFR 866.5420.